Analysis of Meloxicam in Accordance with the United States Pharmacopoeia by Nexera™ XR

Introduction

Meloxicam, inhibits the biosynthesis of prostaglandin, is utilized as an anti-inflammatory and analgesic for arthritis. In the United States Pharmacopoeia (USP), the HPLC method using a UV-Vis absorbance detector is adopted as the test method for meloxicam. This article introduces an example of the analysis of meloxicam in accordance with the USP by Nexera XR, and compatibility with Prominence^TM series using ACTO (Analytical Condition Transfer and Optimization) function.

September 27, 2019 GMT